We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TKNO market cap is 77.38M. The company's latest EPS is USD -0.9031 and P/E is -2.15.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 10.69M | 7.89M | 9.12M | 11.53M | 8.17M |
Operating Income | -22.95M | -14.24M | -8.95M | -7M | -6.57M |
Net Income | -22.47M | -13.29M | -8.82M | -7.15M | -10.15M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 31.3M | 36.89M | 41.42M | 36.68M |
Operating Income | 4.66M | -12.01M | -49.66M | -35.56M |
Net Income | 3.57M | -9.8M | -47.47M | -36.78M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 160.27M | 152.26M | 141.02M | 132.55M | 138.39M |
Total Liabilities | 48.28M | 52.38M | 48.93M | 46.34M | 38.73M |
Total Equity | 112M | 99.89M | 92.09M | 86.21M | 99.65M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 62.91M | 166.51M | 152.26M | 128.59M |
Total Liabilities | 10.51M | 23.31M | 52.38M | 38.55M |
Total Equity | 52.41M | 143.2M | 99.89M | 90.04M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -19.37M | -27.4M | -7.68M | -11.54M | -15.92M |
Investing | -23.42M | -28.15M | -4.31M | -6.65M | -7.62M |
Financing | 5.13M | 10.27M | -25k | -205k | 13.42M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 2.51M | -9.07M | -27.4M | -18.81M |
Investing | -1.74M | -17.52M | -28.15M | -7.74M |
Financing | -1.6M | 110.79M | 10.27M | 12.8M |
Market Cap | 77.38M |
Price to Earnings Ratio | -2.15 |
Price to Sales Ratio | 2.15 |
Price to Cash Ratio | 2.77 |
Price to Book Ratio | 0.88 |
Dividend Yield | - |
Shares Outstanding | 40.73M |
Average Volume (1 week) | 15.31k |
Average Volume (1 Month) | 10.05k |
52 Week Change | 4.97% |
52 Week High | 4.27 |
52 Week Low | 1.62 |
Spread (Intraday) | 0.35 (17.5%) |
Company Name | Alpha Teknova Inc |
Address |
1013 centre road suite 403-b wilmington, delaware 19805 |
Website | https://www.teknova.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions